Supporting Information
Note S1. Note for cell-suspension effect…………………………………………………………….21 Table S1 . Description of the plasmids used in this study……………………………………………22 HEK-293-iRFP-luc-ZsGreen (called HEK-iRFP-Luc-ZsGreen), and human mesenchymal stem cells transgenic for the catalytic subunit of human telomerase (hMSC-TERT) [1] were cultivated in DMEM HEK-HER2-iRFP-Luc-ZsGreen, and HEK-iRFP-Luc-ZsGreen cells has been reported elsewhere [2] .
SEAP assay
The supernatant obtained from the transfected cells was incubated at 65°C for 30 min to inactivate endogenous alkaline phosphatase, and 80 µL of the heat-inactivated medium was placed in wells of a transparent 96-well plate. Then, 100 µL of 2 × SEAP buffer (20 mM homoarginine, 1 mM MgCl2, 21%
(v/v) diethanolamine, pH 9.8) and 20 µL of p-nitrophenyl phosphate (pNPP) solution (120 mM) were added. The time course of absorbance at 405 nm was measured at 37 °C with an EnVision 2104
Multilabel Reader. SEAP production in U/L was quantified from the slope of the time-dependent increase
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in absorbance by using an equation established with appropriate standards. All measurements were made in the region where the relationship was linear in order to avoid saturation effects.
Firefly luciferase viability assay
D-Luciferin (final 500 µM) was added to wells containing cells expressing firefly luciferase (in 96-well plates), and the plate was incubated for 10 min. The luminescence was measured with a Tecan M200
Infinite Pro plate reader. The ratio of luminescence intensity to the control was used as relative cell viability.
Poly-HEMA coating of the dishes
A solution of 6 mg/ml poly(2-hydroxyethyl methacrylate) (poly HEMA, Santa Cruz Biotechnology) in 95 % ethanol was prepared and used to coat the plates or slides (100 µL for a 24-well plate, 50 µL for an
Ibidi µ-Slide 8 well), which were then dried under a cell culture hood overnight and used for experiments.
Observation of invasion and invasion/fusion
HEK-293 or HEK-293T cells were transfected with invasion or invasion/fusion components. These cells were mixed with HEK-HER2-iRFP and/or HEK-iRFP cells, and observed with a Nikon Confocal A1 or Leica SP8 microscope (usually equipped with a x63 oil lens).
Figure-specific protocols are as follows. µL of DMEM containing 0.4% low-melting agarose (Sigma, A4018) were added, and the cells were seeded on an Ibidi µ-Slide 8 well. The slide was left at room temperature until the medium solidified, and
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then mineral oil was applied on the top of the solidified medium to prevent it from drying out. This slide was observed with a Nikon Confocal A1 microscope. well. At 4 hrs after seeding, the cells were observed with a Leica SP8 microscope. The tile scan mode was used to obtain images, which is why the DIC image has a grid-like pattern.
Quantification of invasion using microscopy data.
HEK-293 cells were transfected as described in the legend of 
Evaluation of invasion/fusion by reporter gene assay
Invader cells were transfected with invasion components, pMD2.G (PEF1-VSV-G-pA) and pDB24
(PhCMV-tTA-pA), while receiver cells were transfected with pMX9 (PTET-SEAP-pA), and the two were mixed. After 24 hours, SEAP activity in the cell culture supernatant was measured. Figure-specific protocols are as follows. cell suspension and 20 µL of receiver cell suspension was mixed, and incubated at 37 °C in a 1.5 mL tube.
Next, 500 µL of DMEM was added, and the cells were seeded on a 24-well plate. After 24 hr, SEAP activity in the cell-culture supernatant was assayed. Fig.S7 . The protocol until cell mixing was the same as described for Fig.2c . The mixed cells were seeded on either a normal 24-well plate or a poly-HEMA-coated 24-well plate, and SEAP activity in the supernatant was measured at 24 hours after seeding the cells. 
Evaluation of cell viability of the receiver cells
Figure-specific protocols are given below. The cell suspensions were mixed and incubated at 37 °C in a 1.5 mL tube. Then, 6 mL of DMEM was added, and the cells were seeded in 3 wells of a 6-well plate. At 24 hrs after seeding, cell sorting to analyse iRFP+, ZsGreen+, dsRed± was conducted with a BD Influx cell sorter. 6500 cells of dsRed+ population, dsRed-population, or non-treated HEK-HER2-iRFP-Luc-ZsGreen were suspended in 3 mL of DMEM, and 110 µL of each cell suspension was seeded on a 96-well plate. Cell viability assay was conducted by firefly luminescence assay at the indicated time points. 
Assessment of the effect of invader : target ratio on invasion/fusion efficacy by FACS.
HEK-293T cells were transfected with pRK47, pRK48, pEYFP-C1, and pMD2.G (3000 ng of pRK47, 48, and pMD2.G as well as 1000 ng of pEYFP-C1) for the "invasion/fusion" group. HEK-293T cells were transfected with pRK47, pEYFP-C1 and pcDNA3.1(+) (3000 ng of pRK47, 1000 ng of pEYFP-C1, and 6000 ng of pcDNA3.1(+)) for the "binder-only" condition. At 24 hours after transfection, the invader (or binder control) cells were sorted with a FACS AriaIIIu (BD). For the subsequent protocol, see the legend of Fig. S5 . For observation of the YFP+/iRFP+ population, the mixed cells were sorted with a FACS AriaIIIu at 24 hours after mixing, seeded on an Ibidi µ-Slide 8 well, and observed with a Leica SP8 microscope.
Observation of the fate of fused cells.
See the following figure-specific protocols. See note S1 for additional comments. Error bars represent SEM of three independent experiments. n.s.:
p>0.05, two-tailed Student's t-test Figure S8 : System performance using different antigen binders, transmembrane domains, and an effector. (PhCMV-G3-PDGFRTM-mCherry-pA) G: pRK264 (PhCMV-SP6 [3] (scFv against an irrelevant antigen, synthetic hapten 2,4,6-trinitrophenyl)-CD28TM-CFP-pA). In parallel, HEK-HER2-iRFP and HEK-iRFP cells were transfected with pMX9 (PTET-SEAP-pA) (for the positive control, pDB24 was co-transfected).
The invader cells and the receiver cells were mixed, and seeded on 24-well plates. SEAP activity in the supernatant was measured at 24 hours after seeding the cells. *9_26, G3: Anti-HER2 DARPin [4] . Error bars represent SEM of technical triplicates in a representative experiment. 3d )) (total cell number (invader + receiver) was fixed). Error bars represent SEM of three independent experiments (n=3). Statistical analysis was conducted at Day 5. * p<0.05, ** p<0.01 (against both mock and VSV-G only conditions), two-tailed Student's t-test. Cell killing efficiency appeared to increase as the proportion of invader cells increased. This was thought to be because receiver cells had a greater chance to encounter invader cells. Note that the invader cell population was transiently transfected and included cells that did not take up plasmids; this may account at least in part for the observation that some receiver cells were still growing even at the ratio of 11:1. Note S1: Note concerning the cell-suspension effect.
Entotic cell engulfment is induced by matrix detachment [5] , so the surface condition of cell culture dish was expected to be an important factor in our experiments. In our protocols, we first mixed the invader cells and receiver cells in a 1.5 mL tube. The mixture was incubated for 30 min, and then seeded on a plate or slide (either cell-adhesive condition (normal dish) or cell-suspension condition (dish coated with poly-HEMA). Since the invasion process was relatively fast, we could see cell-in-cell structures with a normal adherent dish. Cell fusion after invasion was also a relatively fast process, and there was no significant difference in the result of tTA transfer-based reporter gene assay between cell-adhesive and cell-suspension conditions (Fig.S7) . So, we used a normal cell-adhesive dish for most of the experiments unless otherwise specified. There was a difference in the major cell fate after cell invasion (without VSV-G expression, Fig.S4a,b ). In the cell-adhesive condition, escape of the engulfed cells from the receiver cells was more frequently observed, as compared with the suspension condition (in the suspension condition, cell death of the engulfed cell seemed to dominate). So, we show results using both the adhesion condition and the suspension condition in Fig.S4 and S7. Table S1 : Description of the plasmids used in this study.
Plasmid Description and Cloning Strategy Reference/Source pRK14
Constitutive CD43EX-YFP expression vector (PhCMV-CD43EX-YFP-pASV40).
Kojima et al [2] pRK21 Constitutive HER2-iRFP670 expression vector (PhCMV-HER2-iRFP-pAbGH).
Kojima et al [2] pRK22
Constitutive iRFP670 expression vector (PhCMV-iRFP-pAbGH). Kojima et al [2] pRK34 Constitutive Ig leader signal-ML39-CD28 transmembrane domain -CFP expression vector (PhCMV-ML39-CD28TM-CFP-pAbGH). DNA fragments encoding Ig leader signal-ML39, CD28TM, and CFP were PCR amplified as follows. Ig leader signal-ML39: The fragment was amplified by oRK41 and oRK9 by using addgene #10794, a gift from Judy Lieberman [6] as a template. This fragment was then digested with NheI/HindIII. CD28TM: The fragment (additionally having cMyc) was amplified by using oRK16 and oRK17 as primers and pAT04 (unpublished, a gift from Aizhan Tastan. This construct encodes a chimeric antigen receptor bearing scFv SP6 provided by Steven A. Rosenberg [3] ) as a template. This fragment was then digested with HindIII/EcoRI. CFP: The fragment (having GGSGG linker in the N-terminal side of CFP) was amplified by oRK22 and oRK23 by using pECFP-C1 (Clonetech) as a template. The fragment was then digested with EcoRI/NotI. These 3 fragments were stepwisely inserted into corresponding sites of pcDNA3.1(+).
This work pRK47
Constitutive Ig leader signal-ML39-CD28 transmembrane domain -dominant negative RhoA (RhoA T19N, devoid of C-termial CAAX domain) expression vector (PhCMV-ML39-CD28TM-RhoA DN-pAbGH). The fragment coding RhoA T19N devoid of CAAX domain (+additional HA tag in the C-termunus) was PCR amplified by using oRK63 and oRK64 as primers, and addgene #12967 (a gift from Gary Bokoch [7] ) as a template. The amplified fragment was digested with EcoRI/ApaI, and was inserted into pRK34 digested with EcoRI/ApaI.
This work pRK48
Constitutive CD43EX-constitutively active RhoA (RhoA Q63L, devoid of CAAX domain) expression vector (PhCMV-CD43EX-RhoA
This work CA-pASV40). The fragment coding RhoA Q63L devoid of C-terminal CAAX domain (+additional FLAG tag) was PCR amplified by using oRK65 and oRK66 as primers, and addgene #12968 (a gift from Gary Bokoch [7] ) as a template. The amplified fragment was digested with AgeI/ApaI, and was inserted into pRK14 digested with AgeI/ApaI. pRK64
Constitutive full length RhoA T19N (dominant negative) expression vector (PhCMV-RhoA DN-pAbGH). RhoA T19N was PCR amplified by using oRK86 and oRK43 as primers, and addgene #12967 as a template. The amplified fragment was digested with HindIII/ApaI, and was inserted into corresponding site of pcDNA3.1(+).
This work pRK65
Constitutive full length RhoA Q63L (constitutively active) expression vector (PhCMV-RhoA CA-pAbGH). RhoA Q63L was PCR amplified by using oRK86 and oRK43 as primers, and addgene #12968 as a template. The amplified fragment was digested with HindIII/ApaI, and was inserted into corresponding site of pcDNA3.1(+).
This work pRK66
Constitutive Ig leader signal-ML39-CD28 transmembrane domain -constitutively active RhoA (RhoA Q63L, devoid of C-termial CAAX domain) expression vector (PhCMV-ML39-CD28TM-RhoA CA-pAbGH). The fragment coding RhoA Q63L devoid of CAAX domain (+additional HA tag in the C-termunus) was PCR amplified by using oRK63 and oRK64 as primers, and pRK48 as a template. The amplified fragment was digested with EcoRI/ApaI, and was inserted into pRK34 digested with EcoRI/ApaI.
This work pRK67
Constitutive CD43EX-dominant negative RhoA (RhoA T19N, devoid of CAAX domain) expression vector (PhCMV-CD43EX-RhoA CA-pASV40). The fragment coding RhoA T19N devoid of C-terminal CAAX domain (+additional FLAG tag) was PCR amplified by using oRK65 and oRK66 as primers, and addgene pRK47 as a template. The amplified fragment was digested with AgeI/ApaI, and was inserted into pRK14 digested with AgeI/ApaI.
This work

pRK85
A plasmid vector for constitutive expression (driven by PSV40) of mCherry. The fragment coding mCherry was PCR amplified by using oRK110 and oRK111 from a mCherry expressing plasmid. The amplified fragment was digested with XmaI/BstBI and was inserted into pcDNA3.1(+) digested with XmaI/BstBI.
This work pRK200
Constitutive Ig leader signal-9_26 [4] (anti-HER2 DARPin)-CD28 transmembrane domain-CFP expression vector (PhCMV-9_26-CD28TM-CFP-pAbGH). The fragment coding 9_26 was PCR amplified by using oRK197 and oRK198 as primers, and 9_26_in_pQE30_2xstop_(corr31) (a gift from Pluckthun lab, ETH Zurich) as a template. The amplified fragment was digested with NheI/HindIII. This fragment was and was inserted into pRK34 digested with NheI/HindIII.
This work pRK201
Constitutive Ig leader signal-G3 [8] (anti-HER2 DARPin)-CD28 transmembrane domain-CFP expression vector (PhCMV-G3-CD28 TM -CFP-pA bGH ). The fragment coding G3 was PCR amplified by using oRK197 and oRK198 as primers, and pDST072_corr (a gift from Pluckthun lab, ETH Zurich) as a template. The amplified fragment was digested with NheI/HindIII. This fragment was and was inserted into pRK34 digested with NheI/HindIII.
This work pRK253
Constitutive CD43EX-DH domain of p63RhoGEF expression vector (PhCMV-CD43EX-DH(p63RhoGEF)-pASV40). The fragment coding DH domain of p63RhoGEF was PCR amplified by using oRK258 and oRK259 as primers, and DNASU (HsCD00441667) as a template. The amplified fragment was digested with AgeI/ApaI, and was inserted into pRK48 digested with AgeI/ApaI.
This work pRK256
Constitutive Ig leader signal-ML39-PDGFR transmembrane domain-mCherry expression vector (PhCMV-ML39-PDGFRTM-mCherry-pAbGH). The fragment coding Ig-ML39 was cut out from pRK34 by SacI/HindIII, and was inserted into pLeo404 (unpublished, a gift from Leo Scheller, coding transmembrane domain of PDGFR and C-terminal mCherry) digested with SacI/HindIII.
This work pRK259
Constitutive Ig leader signal-9_26-PDGFR transmembrane domain-mCherry expression vector (PhCMV-9_26-PDGFR TM -mCherry-pA bGH ). The fragment coding Ig-9_26 was cut out from pRK200 by SacI/HindIII, and was inserted into pLeo404 digested with SacI/HindIII.
This work pRK260
Constitutive Ig leader signal-G3-PDGFR transmembrane domainmCherry expression vector (P hCMV -G3-PDGFR TM -mCherry-pA bGH ). The fragment coding IgG3 was cut out from pRK201 by SacI/HindIII, and was inserted into pLeo404 digested with SacI/HindIII.
This work pRK264
Constitutive SP6-PDGFR transmembrane domain-mCherry expression vector (PhCMV-SP6-PDGFRTM-mCherry-pAbGH). SP6 (including secretion signal sequence) was PCR amplified by using oRK174 and oRK175 as primers and pAT04 as a template. This fragment was digested with NheI/HindIII. Also, a fragment coding CD28TM-RhoA DN was cut out from pRK47 with HindIII/ApaI. These 2 fragments were inserted in pcDNA3.1(+) digested with NheI/ApaI, yielding pRK143 (PhCMV-SP6-CD28TM-RhoA DN-pAbGH). A fragment coding SP6 was cut out from pRK143 by SacI/HindIII, and was inserted into pLeo404 digested with SacI/HindIII.
This work pDB24
Constitutive tTA expression vector (PhCMV-tTA-pASV40). tTA was PCR amplified by using oDB23 and oDB24 as primers and pSAM200 [9] as a template. This fragment was digested with NheI/NotI, and was inserted into pEGFP-N1 (Clontech) digested with NheI/NotI.
This work pMX9
tTA responsive SEAP expression vector (PTET-SEAP-pA). Folcher et al [10] pcDNA3.1(+) Empty vector bearing hCMV promoter and multicloning site (MCS).
(PhCMV-MCS-pAbGH). 
